Treosulfan, thiotepa and fludarabine conditioning regimen prior to first allogeneic stem cell transplantation in acute myeloid leukemia and high-risk myelodysplastic syndromes: a single center experience

MeSH terms

• Busulfan / therapeutic use
• Graft vs Host Disease*
• Hematopoietic Stem Cell Transplantation*
• Humans
• Leukemia, Myeloid, Acute* / therapy
• Myelodysplastic Syndromes* / therapy
• Thiotepa / therapeutic use
• Transplantation Conditioning
• Vidarabine / therapeutic use